SEMIGRAN MARC enters RENOVACOR, INC. with 35.23K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/7/2021ACC: 0000899243-21-035295
Officer· Chief Medical Officer
Since Sep 2021
35.23K
Baseline shares
100% direct
35.23K
Direct ownership
1 position
88.99K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned35.23K
Total
35.23K direct35.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 35.23K | Direct |
| Total | 35.23K | 35.23K direct |
Derivative Holdings1
Options
DirectUnderlying security
Common Stock
Underlying shares
88.99K
Shares owned
N/A
Exercise price
10.83
Expiration
—
Exercise window
—
Total
Underlying
88.99K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options Direct | Common Stock | 10.83 | — | — | 88.99K | N/A |
| Total | 88.99K | 0.00 | ||||